Recombinant RSV (Palivizumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all RSV (Palivizumab Biosimilar) products
- RSV (Palivizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
-
Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This RSV (Palivizumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Palivizumab Biosimilar - Anti-RSV mAb
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- RSV (Palivizumab Biosimilar)
- Abstract
- RSV (Palivizumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
-
MEDI-493, Synagis
Palivizumab is a humanized monoclonal antibody of isotype IgG1k produced by recombinant DNA technology. It targets the epitope in the A antigenic site of the respiratory syncytial virus (RSV) F protein. - CAS-No
- 188039-54-5
-
You are here:
